Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
Type
Article, LetterAuthor/s
Rockett, R.Basile, K.
Maddocks, S.
Fong, W.
Agius, J.E.
Johnson-Mackinnon, J.
Arnott, A.
Chandra, S.
Gall, M.
Draper, J.
Martinez, E.
Sim, E.M.
Lee, C.
Ngo, C.
Ramsperger, M.
Ginn, A.N.
Wang, Q.
Fennell, M.
Ko, D.
Lim, H.L.
Gilroy, N.
O'Sullivan, M.V.N.
Chen, S.C.-A.
Kok, J.
Dwyer, D.E.
Sintchenko, V.
Date
2022Funding information
JP21wm0125002
National Institute of Allergy and Infectious Diseases, NIAID: JP20fk0108412, JP20nk0101632, JP21fk0108104, JP21fk0108615
Japan Agency for Medical Research and Development, AMED
Ministerio de Sanidad, Consumo y Bienestar Social, MISAN: APPRISE 1116530
National Health and Medical Research Council, NHMRC
Ministry of Health, Labour and Welfare, MHLW: 20HA2007
Licence
OtherFaculty/School
Faculty of Medicine and HealthShare